Lung Cancer News

High cardiorespiratory fitness was linked to reductions in head and neck, colon, esophagus, stomach, pancreas, liver, rectum, kidney and lung cancers among men, according to a study published in the British Journal of Sports Medicine.

E-cigarette use increased overall and in those with a history of CVD who quit cigarette smoking from 2019 to 2020, according to a study published in JAMA Network Open.

Tarlatamab exhibited activity among patients with relapsed or refractory small cell lung cancer, according to the agent’s manufacturer.

The FDA announced several regulatory actions the past few weeks.

Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.

The FDA granted regular approval to pralsetinib for treatment of certain patients with non-small cell lung cancer.

A review of oncology trials showed approximately two-thirds did not report results on any of three key platforms within 1 year of completion.

A meta-analysis performed by an international group of researchers revealed no association between depression or anxiety and increased overall cancer risk.

The FDA announced several regulatory actions the past few weeks.

Martin J. Edelman, MD, has been appointed the first chair of the department of medical oncology at Lewis Katz School of Medicine at Temple University.